What is it about?
Antibody response was evaluated by a quantitative anti-SARS-CoV-2 RBD IgG commercial assay and by virus microneutralization test (MNT), in order to establish a threshold of anti-RBD binding antibody units (BAU) able to predict a robust (≥1:80) MNT titre in vaccinated HCW and in COVID-19 recovered patients. A threshold of 2,000 BAU/mL is highly predictive of strong MNT response in vaccinated individuals and may represent a good surrogate marker of protective response.
Featured Image
Read the Original
This page is a summary of: Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine, Clinical Chemistry and Laboratory Medicine (CCLM), September 2021, De Gruyter,
DOI: 10.1515/cclm-2021-0700.
You can read the full text:
Contributors
The following have contributed to this page
